EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?

Myfanwy Graham iD, Dereje Assefa, Adrian Carter, Suzanne Nielsen iD

Drug and Alcohol Review · 2026-07 · 45 (5)

DOI: 10.1111/dar.70203 ↗

At a glance

Übersichtsarbeit in Drug and Alcohol Review, published online on 2026-07-15. Written by Myfanwy Graham and 3 co-authors. Institution: Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia. Major MEDLINE topics: Dronabinol, Medical Marijuana, Cannabis. 132 references. The full text is freely available (open access, CC BY 4.0). Funded by: Department of Health and Aged Care, Australian Government, National Health and Medical Research Council, Department of Health, Disability and Ageing.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

There have been concerted research efforts internationally to examine the health effects of higher delta‐9‐tetrahydrocannabinol (THC) concentration cannabis products and to design policies to reduce potential negative health effects of their use. This study identifies international policy approaches for regulating higher THC products relevant to the Australian medicinal cannabis program.

Methods

An environmental scan of international literature and policy as part of a broader study commissioned to inform Australian policy. Methods were prospectively registered with the Open Science Framework: 10.17605/OSF.IO/HNFUT . Peer‐reviewed and grey literature on international policy approaches were identified through searches for ‘high potency THC’ and ‘policy’. The literature was then narratively synthesised.

Results

We identified 76 publications and other sources that described policy approaches recommended or implemented in five jurisdictions: Canada; Germany; the Netherlands; the United States; and Uruguay. Approaches included setting a threshold for cannabis flower THC concentration at or below the biological THC limit of 30%–35% found in the plant and a risk‐tiered model for highly concentrated THC dosage forms. THC limits per dose and per package have been applied to edible products. Additional approaches included quantity limits, packaging and labelling requirements, pharmacovigilance, and education. Discussion and Conclusions Policy approaches for higher THC concentration cannabis products could be adapted to the Australian regulatory environment to reduce potentially harmful THC exposure.

Subjects

MeSH terms (MEDLINE)

DronabinolMedical MarijuanaCannabisHumansAustralia

Author keywords

delta‐9‐tetrahydrocannabinolhigh THC potencymedicinal cannabispolicypublic health

Substances

DronabinolMedical Marijuana

Authors and institutions

  • Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
  • School of Psychological Sciences and the Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia.
  • Monash Bioethics Centre, School of Philosophy, History and International Studies, Monash University, Melbourne, Australia.

ORCID profiles: Myfanwy Graham, Suzanne Nielsen

Funding

  • Department of Health and Aged Care, Australian Government
  • National Health and Medical Research Council
  • Department of Health, Disability and Ageing

Cite

APA

Graham, M., Assefa, D., Carter, A., & Nielsen, S. (2026). International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?. Drug and Alcohol Review, 45(5). https://doi.org/10.1111/dar.70203

Vancouver

Graham M, Assefa D, Carter A, Nielsen S. International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?. Drug and Alcohol Review. 2026;45(5). doi:10.1111/dar.70203

BibTeX
@article{Graham2026,
  author = {Graham, Myfanwy and Assefa, Dereje and Carter, Adrian and Nielsen, Suzanne},
  title = {International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?},
  journal = {Drug and Alcohol Review},
  year = {2026},
  volume = {45},
  number = {5},
  doi = {10.1111/dar.70203}
}
Start for free →